Topics
Sector
Geography
Subject

Video Centre

Event Videos

964
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

Please find the latest videos from entire, recent NextLevel LifeSciences events.

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 23-24, 2018
Presentation

The Sentient Enterprise or ‘Sentient’ healthcare as a vision in using data

Related topics: Pharmaceutical/Biotech, MedTech, Market Access & HEOR, Real-World Evidence & Late-Phase Research, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
  • Another approach to personalised medicine and outcome-based reimbursement: The sentient healthcare enterprise.
  • The technology and trends to get there.
  • The data and analytical democracy of all stakeholders.
  • The major challenges and how to handle those in order to manage the healthcare costs.
  • Examples from other industries.
Speaker

Stephen A. Brobst
CTO
Teradata Corporation

Presentation

Artificial intelligence for drug discovery, biomarker development and aging research

Related topics: Pharmaceutical/Biotech, MedTech, Diagnostics, IT & Big Data, Discovery & R&D Innovation
Availability: FREE
Speaker

Alex Aliper
President
Insilico Medicine

MedTech Access Leaders Forum

Berlin, Germany - December 5-7, 2017
Presentation

How to balance evidence demands between US and International Markets

Related topics: MedTech, Europe, USA, Market Access & HEOR
Availability: FREE

Planning for a global product launch means a coherent evidence plan and value dossier must address the needs of multiple geographies. This session will review the evolving perspectives of US payers on evidence for medical devices, and contrast these trends with major EU markets and Japan. Specific topics to be addressed will include:

  • US Medicare and private payer bundled payment models.
  • New bundling of In Vitro Diagnostics under Medicare outpatient rules.
  • British requirements for Specialised Services.
  • French programs to generate real world evidence.
  • Germany’s trial regulation.
  • Japan’s new HTA requirements.
Speaker

Stephen Hull
Principal and Founder
Hull Associates, USA

Presentation

Real World Evidence the key to smart medical device market access

Related topics: MedTech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • It is all about the quality of the data.
  • RWE to understand target indication and plausibility of clinical trial success.
  • Single arm / registry to comparative effectiveness data.
Speaker

Mattias Kyhlstedt
CEO
Synergus AB, Denmark

MedTech Commercial Leaders Forum USA

Princeton - New Jersey - November 6-8, 2017
Presentation

Embedding market access into the mergers & acquisitions process

Related topics: MedTech, USA, Market Access & HEOR
Availability: FREE
  • Market access supporting key value processes
  • The mergers & acquisitions process
  • Key issues examined during due diligence
  • Anonymised case studies
Speaker

Rob Wenthold
Vice President
Boston Healthcare Associates

Presentation

Preparing commercial teams to demonstrate value, not features

Related topics: MedTech, USA, Commercial
Availability: FREE
  • More professional purchasers and decision makers need a different approach
  • Why price is not the priority for providers (even though it seems so)
  • Developing the value message: Quantifying benefits
  • Roadmap to preparing commercial teams to use value to justify price
  • Best practices from real case studies
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

PharmaValue Stakeholder Forum

Berlin, Germany - 10 October, 2017

MedAffairs Leaders Forum (Autumn)

Berlin, Germany - October 10-13, 2017
Presentation

Medical communications: Integrating the patient voice

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care, Life Sciences (not-specific)
Availability: FREE
  • Identify key questions that should be asked when determining if medical communications are meaningful for patients.
  • Working with stakeholders to provide insights for patient-centric communications.
  • Describe two case studies that demonstrate how medical communications to patients were vastly improved by applying patient insights.
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

Promoting the patient voice in evidence generation and global market access planning

Related topics: Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific), Life Sciences (not-specific)
Availability: FREE
  • Regulator and payer perspectives on patient-centric data in decision making.
  • Highly successful strategies for leveraging the patient voice in RWE research.
Speakers

Leanne Larson
Corporate VP, Observational Research
PAREXEL

Oliver Leatham
VP Heron Commercialization
PAREXEL

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - October 10-12, 2017
Presentation

Is there a need for a centralised, European HTA agency and predictable, transparent European standards?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • How similar are HTA agencies in methods and procedures?
  • Is there a development towards shared standards?
  • What are stakeholders doing to encourage harmonisation/standardisation?
  • Is there a need for a European institution to get the job done?
Speaker

Finn Boerlum Kristensen
Managing Director Science & Policy, Faculty of Health Sciences, University of Southern Denmark
Former EUnetHTA Executive, Committee Chairman and EUnetHTA Secretariat Director

Presentation

The impact of PROs on HTA decision-making

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Current perception of PRO evidence among payers and its influence in decision-making 
  • Differences between payer and regulators in assessing PRO evidence
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS

Medical Affairs Leaders Forum USA

Princeton, New Jersey, USA - July 25-27, 2017
Presentation

Achieving world-class execution in medical affairs

Related topics: Pharmaceutical/Biotech, USA, Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE

With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.

Speakers

Robert Groebel 
Vice President - Global Medical Strategy 
Veeva

Brian Harper
Senior Director, Medical Content Strategy
Veeva 

Presentation

The role of MSLs in the development of pre-market communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Commercial, Global (non-specific), Medical Science Liaison, Life Sciences (not-specific)
Availability: FREE
  • Medical Affairs and MSL synchronicity: Linking efforts to ensure a positive outcome.
  • MSLs and KOLs: The data sweet spot: Finding balance within the current regulatory environment.
  • The role of MSLs in audience engagement: Strategic & tactical approaches to engagement.
  • MSL-directed educational communications: An appropriate path forward.
  • Measuring the impact of MSL-driven activities: Applying metrics to establish impact.
Speaker

Tim Day
Principal 
Innovative Strategic Communications

PharmAccess Leaders Forum (Spring)

Milan, Italy - May 3-5, 2017
Presentation

HTA in the changing development and regulatory landscape

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • What is driving changes such as conditional market authorisation and adaptive pathways?
  • What are the challenges for HTA agencies and their evaluation approaches?
  • What are the critical success factors for pharma companies?
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS

Presentation

Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing Upstarts (marketers of biosimilars) and Defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

MedTech Commercial Leaders Forum (Europe)

Zurich, Switzerland - February 20-22, 2017
Presentation

CPQ and Tender Management: How can I optimise my commercial strategy?

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE

Prioritising and targeting the best business opportunities is crucial for medical device
companies to create an optimal offering strategy while controlling and minimising
discounting. Therefore it is critical for global pricing, commercial and marketing
leaders to standardise their price configuration, quotes and tender processes with
best practices. This approach will lead to new business and optimal deal structures,
resulting in higher revenues and margins.

Speaker

James Robinson
Director Industry Solutions
ModelN, Switzerland

Presentation

How reimbursement/funding drive sales and adoption for medical technologies?

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • Overview of the main reimbursement systems in Europe.
  • Price: The main barrier for medical technology.
  • When is it (really) necessary to apply for reimbursement?
  • Demonstrating value to access healthcare payment pathways.
  • Moving ahead: The new EU perspective on medical innovations.
Speaker

Ernesto Nogueira
Managing Director 
ValueConnected

Medical Affairs Leaders Forum (Spring)

Zürich, Switzerland - February 28 - March 2, 2017
Presentation

Getting to world class medical affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • Challenges facing medical affairs functions today.
  • Medical affairs transformation as pipelines shift to specialty care.
  • Getting to ‘world class’ through focus on delivering an exceptional stakeholder experience.
Speaker

Sital Kotecha 
Medical Strategy Director, Europe
Veeva Systems, UK

Presentation

Applying the patient perspective to medical planning

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
  • Apply a single framework for patient centricity in medical affairs.
  • Uncover what patients value and how it changes on their treatment journey.
  • Structure and prioritise innovative medical activities in a patientcentric way.
Speaker

Dominic Sloane 
Development Director
Adelphi Communications, United Kingdom

R&D Data Intelligence Leaders Forum

Basel, Switzerland - January 24-26, 2017
Presentation

How deep data and predictive analytics can enhance R&D portfolio management

Related topics: Pharmaceutical/Biotech, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
  • Identify new patient target groups for innovative drug development by applying predictive analytics to real world and trial data.
  • Enhance R&D productivity by mapping the real world using predictive analytics.
  • Facilitate the implementation of Adaptive Pathways through predictive analytics.
Speakers

Kerstin Bode-Greuel
Dir. Business Development & Marketing RWE
QuintilesIMS, Germany

Rolf Günther
Chief Information Officer
Qlaym Healthcare, Germany

Presentation

Demystifying Artificial Intelligence for Pharma in the Era of Big Data

Related topics: Pharmaceutical/Biotech, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
  • Convergence of data, technology and advances in the field ofneural networks.
  • Increased opportunities for the use of real-world evidence data sets from the genome revolution, clinical trials, medical imaging and electronic health records.
  • Accelerate the use of Artificial Intelligence (AI) within Pharma R&D to develop actionable insights.
Speaker

Andrea de Souza
Global Business Development Lead, NVIDIA, USA

MedTech Access Leaders Forum

Berlin, Germany - December 6-8, 2016
Presentation

Understanding The Changes in European Market Access in Medical Devices

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
Speaker

Mattias Kyhlstedt
CEO
Synergus AB, Sweden

Presentation

Translating hospitals’ needs into actual value stories

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Identifying decision-makers’ needs.
  • Assessing the relevant data to support claims.
  • Building a concrete value story.
  • Next steps: Teams, not tools, demonstrate value.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

London, UK - October 18-20, 2016
Presentation

How digital medical communications can support a global medical affairs strategy: Opportunities and compliance considerations

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
Speakers

Rob Barker
CEO, Succinct Medical Communications, UK

James Turnbull
Digital Technical Director, Succinct Medical Communications, UK

Presentation

Compassionate use programs as a strategy for market access

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
  • Why and when to run them?
  • Benefits and pitfalls.
  • Strategic considerations.
  • Case study: The French ATU programme.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services
PRA Health Sciences

PharmAccess Leaders Forum (Autumn)

Berlin, Germany - September 27-29, 2016
Presentation

Leveraging RWE to support market access: Lessons learned

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE

Market access is value contextual, thus using RWE to secure appropriate market access allows evidence to reflect effectiveness in the real world where protocols may not be followed, patients don’t take their medications, and where every population is viewed as unique requiring data to reflect that specific population . This presentation walks through the reality of developing RWE for an EUmarketed, post-anaesthesia medication using a retrospective observational study format and demonstrates the importance of thinking carefully about your strategy (the benefits, risks, costs and mitigations) before embarking.

Speaker

Mervyn D. Hall
Director of Market Access – Europe
Truven Health Analytics, UK

Presentation

Cell & gene therapies: A global perspective of HTA, funding & reimbursement challenges

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Overview of cell & gene therapies.
  • Health technology assessment & cost effectiveness challenges.
  • Who pays? Healthcare system determinants of funding / reimbursement.
  • Affordability: Pricing and budget impact challenges.
  • Lessons learned: Early case studies.
Speaker

Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Market Access in Latin America Leaders Forum

São Paulo, Brazil - July 12-14, 2016
Presentation

Is your market access organization ready for the evolving access challenges in Latin America?: A primer on organizational development to reflect marketplace changes.

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Latin America
Availability: FREE
Speakers

Miguel Martin de Bustamante
Associate, CBPartners

Sandeep Duttagupta
Vice President, CBPartners

Medical Affairs Leaders Forum (Asia)

Singapore - July 20-21, 2016
Presentation

Practical strategies for implementing RWE studies in Asia Pacific

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Differences between real-world evidence studies and randomized controlled trials.
  • Asia Pacific country specific examples of real-world evidence studies.
  • Local regulations on study approval and execution.
  • KOL value and working with investigators in APAC.
Speakers

William Maier
Chief Scientific Officer, Mapi Group, UK

Isabelle Grau
Director, Real World Evidence APAC, Mapi Group, Australia

Presentation

Navigating post-marketing requirements worldwide: What to anticipate as you move towards submission

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  • Review of post-marketing requirements in the USA, Europe, and South Korea.
  • How to interpret the demand of the authorities,
  • Proactive planning to drive design.
  • Real-world case studies from the USA, Europe and South Korea.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services,
PRA Health Sciences

Nordic Market Access Leaders Forum

Stockholm, Sweden - April 19-20, 2016
Presentation

Global trends in market access: Finding the balance between budget management and patient access

Related topics: Pharmaceutical/Biotech, Europe, Nordic, Market Access & HEOR
Availability: FREE
Speaker

Carlo Ciapparelli
General Manager, Northern Europe
IMS Health, Sweden

PharmAccess Leaders Forum (Spring)

London, UK - April 26-28, 2016
Presentation

Understand the real drivers of HTA decision-making in oncology: What clinical and economic factors influence positive vs negative recommendations?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Oncology
Availability: FREE
  • How do payers evaluate products in an increasingly crowded marketplace.
  • How successful are companies in getting new products approved?
  • Comparing major payers: Where are similarities and where are the difference in their evaluations?
  • Do companion diagnostics make a difference in the approval success rate?
Speaker

Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands

Presentation

Global review of innovative pricing arrangements: Shifting dynamics and new considerations

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Payer perception/considerations of innovative pricing in the context of health budget pressures.
  • Analytics overview of geographies and therapeutic areas where key changes are occurring.
  • Key strategic lessons over how these agreements are being designed.
Speaker

Gustav Ando
Vice President of Life Sciences
IHS

Medical Affairs Leaders Forum (Spring)

Berlin, Germany - February 22-23, 2016
Presentation

Medical affairs organisational models: A market-driven approach

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Assessing the market through a medical affairs lens.
  • How market specific characteristics influence medical affairs capabilities.
  • How the market dictates medical affairs size and structure.
  • How specific roles within medical affairs vary due to market characteristics.
Speaker

Suma Ramadas
Managing Director, Medical Affairs
Campbell Alliance, USA

Presentation

Wiring medical affairs capabilities into the organisational DNA

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Why linking medical affairs strategy and capability together is important.
  • How to build capabilities in medical affairs functions at different stages of their growth.
  • Future challenges in building medical affairs capability.
  • Sharing case study examples.
Speaker

Sophie Hall
Head of Capability Building Practice
Pope Woodhead, UK

Medical Device Commercial Leaders Forum (Europe)

Brussels, Belgium - February 16-18, 2016
Presentation

Developing a commercial model based on value

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE
  • Early stage or product launch: When is the right moment to focus on value?
  • Identifying the key value propositions to drive the market.
  • Building the relevant economic data to support value claims.
  • Case example: From feature-centric to value-based model
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Presentation

Six key buyer trends reshaping MedTech selling & pricing

Related topics: MedTech, Europe, Market Access & HEOR, Commercial
Availability: FREE

The MedTech industry is at an inflection point. Healthcare providers at every level are professionalising their procurement and creating tectonic shifts in their demands on your pricing, sales, and tendering and contracting operations. While the industry appears to be aware of these shifts and what the impacts will be, many MedTech companies are struggling to identify and prioritise the changes they need to make to stay ahead of these trends without sacrificing revenue or growth.

Speaker

Peter Zimmermann
Director Customer Success Europe
Model N, Switzerland

R&D Big Data Leaders Forum

London, UK - January 19-21, 2016
Presentation

From Big Data to precision medicine: Trends, challenges & opportunities

Related topics: Pharmaceutical/Biotech, Diagnostics, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
Speaker

Thomas Wilckens
Chief Executive Officer, CSO & Founder, InnVentis, Germany

Presentation

Breaking the classical barriers to collaboration and scientific discovery: Distance and data size

Related topics: Pharmaceutical/Biotech, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE

Life sciences organisations need to dramatically reduce analytics time and speed up clinical interventions, but most still rely on shipping physical disks due to inherent problems with existing networks and transfer protocol inefficiencies. Spending days to transport data is not a viable option, this session will explore technology infrastructure for file transfer that will catalyse the transition from 1GbE to 10GbE and beyond.

  • Enabling geographically distributed collaborative teams to exchange huge data sets at maximum speed, regardless of distance and network conditions.
  • Utilising proven, secure and reliable transfer technology, widely adopted for business-critical data movement.
  • Transferring large data sets, including next-generation genomic sequencing sets, amounting to hundreds of gigabytes.
Speaker

Per Hansen
Regional Manager Sales Engineering EMEA, Aspera (an IBM Company),UK

MedTech Access Leaders Forum

December 8-10, 2015
Presentation

Demonstrating value in the changing US healthcare landscape

Related topics: MedTech, USA, Market Access & HEOR
Availability: FREE
  • The changing US landscape.
  • Evolving care delivery and incentive models.
  • Implications for innovators.
  • Organising to demonstrate value in the new environment
Speaker

Robert Wenthold
Executive Director
Boston Healthcare Associates

Presentation

Building economic evidence towards compelling value propositions

Related topics: MedTech, Europe, Market Access & HEOR
Availability: FREE
  • Early stage or commercialisation: When is the right moment to focus on economic evidence?
  • Identifying what decision-makers are looking for.
  • Less is more: Identifying the relevant data to support value claims.
  • Case example: From evidence to compelling value proposition.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands

Medical Affairs Leaders Forum (Autumn)

October 21-22, 2015
Presentation

Evaluating critical methodological issues to optimally address the research question: What are the trade-offs among study designs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE

Research questions around real-world evidence development can include a breadth of evidence needs including the prevalence, clinical characteristics, treatment patterns and effect, etc. of a given cohort and/or sub-cohort. Addressing the question(s) can be complicated by the size/characteristics of the cohort and the complexities of the health system. Consequently, we propose a practical and feasible approach to assessing study design options which we believe will meet both the research objectives as well as consider the realities of timelines and budget constraints. We will discuss a number of options for study design and cohort identification, including use of administrative claims and/or electronic healthcare records, sitebased recruitment, and web-survey panelists. We will identify a set of common methodological challenges and discuss the relative strengths of each approach in addressing these issues.

Speaker

Teresa K Wilcox
Scientific Director, Real World Evidence, Evidera, USA

Presentation

Best practice approaches in phase 4 clinical operations and implementation

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker

Alexandra Adams
Director, Late Phase, Europe
Chiltern, UK

PharmAccess Leaders Forum (Autumn)

October 13-15, 2015
Presentation

Blueprint for market access: Strategic insights from the regulatory and HTA review process

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE

An interactive session exploring the lifecycle of a drug including:

  • Comparison of regulatory and HTA agency clinical trial evaluations
  • Impact of the label indications on the HTA review process
  • HTA opinion on submitted evidence
Speaker

Yin Ho
CEO
Context Matters Inc., USA

Presentation

Biologics, biosimilars, and interchangeable biologics: US update after first launch

Related topics: Pharmaceutical/Biotech, USA, Market Access & HEOR, Biosimilars
Availability: FREE
  • The US is essentially a “secondary” market for biosimilars; as such, what can be learned from other markets?
  • The business model for biosimilars, neither branded or generic products, is likely to be different in the US than in other markets, especially when it comes to pricing. How will business models be structured and operate?
  • With only 5 applications and 1 approval to date, there isn’t yet a clear regulatory pathway for biosimilars in the US. What might that pathway look like when more fully developed?
  • With originators of branded products making more defensive manoeuvres in the US than in other countries, lifecycle management of biosimilars is likely to be different in the US than elsewhere. What differences will there be?
Speaker

Kathleen E. Hughes
Vice President, Avalere Health, USA

Medical Affairs Leaders Forum Asia

Singapore - August 4-5, 2015
Presentation

RWE in Asia: Has its time finally come?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  •  Current state of RWE in Asia markets.
  •  Key trends and how it is evolving.
  •  What this means for healthcare companies.
Speaker

Sheryl Jacobson
Asia Head of Life Science and Healthcare Consulting 
Deloitte

Presentation

Mapping real-world centers: Can it be done?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
Speaker

Karen Wai
Vice President, Regional Managing Director Real-World & Late Phase Research, Asia Pacific
Quintiles, Singapore

Clinical Research in Turkey Middle East and North Africa Leaders Forum

Dubai - United Arab Emirates - June 8-9, 2015
Presentation

The importance of achieving recruitment targets in MENA

Related topics: Pharmaceutical/Biotech, Clinical, Middle East
Availability: FREE
  •  Why is recruitment important?
  •  Issues seen in studies (generally not just MENA).
  •  What are the possible reasons for this?
  •  Are there differences between MENA and ROW in patient recruitment numbers and retention rates?
  •  How could we actively prevent these issues?
  •  Case studies (both good and bad) & lessons learned.
Speaker

Myriam El-Khazen
General Manager 
INC Research, Greece

Market Access & Commercial Excellence Forum Asia

Singapore - August 5-6, 2015
Presentation

Building the market to gain market access in Asia-Pacific countries: From a transactional player to a strategic partner

Related topics: MedTech, Market Access & HEOR, Asia Pacific
Availability: FREE
  • What value does your technology bring to address the needs of the country’s health system?
  • How can you develop the market to create a receptive and favorable environment for your technology?
  • Case study: Established vs. emerging markets.
Speaker

Anne Smart
Director
Navigant, USA

Oncology Clinical Leaders Forum

Brussels, Belgium - May 11-12, 2015
Presentation

Mass balance/ADME studies in oncology patients: Successful answers to the challenge in Central and Eastern Europe

Related topics: Pharmaceutical/Biotech, Europe, Clinical, Central Eastern Europe, Oncology
Availability: FREE
  • Patient pharmacology services: Concept and operational set up.
  • ADME concepts, incl. micro-dose and tracer-dose.
  • Underlying dossier requirements incl. preclinical safety package.
  • General design considerations incl. radiodose and radioburden calculation.
  • Devil is in the details: Operational challenges.
  • Selection of geographic region and patient population.
  • Ethical aspects.
Speaker

Agnes Rethy 
Associate Director of Clinical Operations
EDS Patient Pharmacology Services
PRA Health Services

Presentation

Multilateral recruitment approach for early phase oncology trials: Weights and balances

Related topics: Pharmaceutical/Biotech, Clinical, Global (non-specific), Oncology
Availability: FREE
  • Key challenges in early phase oncology recruitment.
  • Therapeutic, supportive and other compounds from trial management perspective.
  • Pros and cons of early phase trials for the investigator and for the cancer patient.
  • Role and potential of professional CPU (Clinical Pharmacology Unit) within indication.
  • Satellite Centre Concept for proper recruitment and controlled quality.
Speaker

Istvan Udvaros 
Medical Director, Project Director of Oncology
SGS LSS Clinical Research, Belgium

Medical Affairs Leaders Forum Spring

Berlin, Germany - February 26-27, 2015
Presentation

Flexible resourcing & talent management models for medical affairs teams

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Evaluating and developing a medical affairs team’s skill sets for more flexibility.
  • Developing a life-cycle dependent model for flexible medical affairs resourcing.
  • The impact of a flexible resourcing approach on talent acquisition.
  • The role of strategic outsourcing for medical affairs.
Speaker

Keith Morris
Vice President, Medical Affairs
Campbell Alliance, USA

Presentation

MSL Technology Showcase

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology, Medical Science Liaison
Availability: FREE
Speaker

Gijs Hubben
CEO
BaseCase, Germany

Medical Device Commercial Leaders Forum Europe

Brussels, Belgium - February 18-19, 2015
Presentation

Roadmap to market access: Demonstrating value to purchasers

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • Analysis of the real case of a global medical device companythat launched an innovative device to prevent seriouscomplications of a disease and was facing significant market barriers across Europe.
  • In spite of the product’s clinical benefits, commercial teams couldnot quantify the value of the product to purchasers and decisionmakers.
  • The solution came with the development of a process positioningthe best product evidence to directly address the clinical andeconomic needs of stakeholders.
  • Commercial teams were able to quickly demonstrate and quantifyvalue, helping hospitals and clinics to understand the costs and benefits of adopting the medical innovation.
Speaker

Ernesto M. Nogueira 
Managing Director
ValueConnected, Netherlands

Presentation

Accelerating sales with sales driven marketing

Related topics: MedTech, Commercial
Availability: FREE

In today’s digital age, marketers can use marketing automation and analytics technology enabling them to be hyper-relevant to the customer via online channels. But what happens when the customer schedules a call or meeting with your sales team? How do you know whether or not your content performs well during this offline phase of the customer journey? Learn how to grow your business by supporting your sales and indirect channels with sales driven marketing.

Speaker

Pieterjan Bouten
Chief Executive Officer
Showpad, Belgium

Medical Device Hospital Procurement and Payer Forum

Brussels Belgium - 17 February, 2015

Register to view both free videos and browse premium content (and event documentation).

964
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!